In relation to this, it has been found that 90%–95% of human bone marrow-MSCs express CD105 (endoglin) as well as 50% of CAFs in the tumor stroma of breast cancer patients (BCPs) express CD105 (Pasanen et al., 2016). The gene discussed is ENG; the disease is breast carcinoma.